Reported covered position: Legislative Correspondent, Sen. Menendez
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR 5376--Inflation Reduction Act of 2022--Drug pricing/biosimilars Women's health Biosimilars
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ORGANON & CO. via ORGANON & CO.
2026 · third_quarter · Q3
One Big Beautiful Bill Act (P.L. 119-21) - provisions related to Medicaid coverage, rural health funding, and drug pricing. Drug pricing, women's health, biosimilars.
FY27 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
2026 · second_quarter · Q2
FY27 appropriations.
Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (Public Law 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON & CO. via ORGANON & CO.
2026 · first_quarter · Q1
FY27 appropriations.
Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (Public Law 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON & CO. via ORGANON & CO.
2025 · fourth_quarter · Q4
Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (PL 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing
FY26 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON & CO. via ORGANON & CO.
2025 · third_quarter · Q3
Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (PL 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing
FY26 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON & CO. via ORGANON & CO.
2025 · second_quarter · Q2
Drug pricing Women's health Biosimilars One Big Beautiful Bill Act (PL 119-21)--provisions related to Medicaid coverage, rural health funding, and drug pricing
FY26 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON & CO. via ORGANON & CO.
2025 · first_quarter · Q1
Drug pricing Women's health Biosimilars
FY25 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON & CO. via ORGANON & CO.
2024 · fourth_quarter · Q4
FY25 appropriations
Drug Pricing Women's health Biosimilars
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON & CO. via ORGANON & CO.
2024 · third_quarter · Q3
HR 5376--Inflation Reduction Act of 2022--Drug pricing/biosimilars Women's health Biosimilars
FY25 appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE